Home : Contact Us

About Us

Product Pipeline

Technology

Partnerships

Investors

Careers

Vision and Focus

Business Strategy

People and Facilities

Inflammatory Arthritis

HIV/AIDS Vaccine

Congestive Heart Failure

Huntington's Disease

Hyperlipidemia

Technology Platform

About Gene Therapy

Partners

Strategy

Manufacturing

Intellectual Property

Corporate Governance

Stock Information

Press Releases

Event Calendar

SEC Filings

Financial Reports

Analysts

Webcasts/Presentations

Contact Information

E-mail Alerts

Information Request

Benefit Summary

Jobs

Internships

INVESTORS

HOME >  Press Releases

Investor Relations Home Corporate Governance Stock Information » Press Releases Event Calendar SEC Filings Financial Reports Analysts Webcasts/Presentations Contact Information E-mail Alerts Information Request

Receive E-mail Alerts Keyword Search 2010 | 2009 | 2008 | 2007 | 2006 Date Title   06/01/10 Targeted Genetics Corporation Reports Fourth Quarter and Full Year 2009 Financial Results 05/30/10 Targeted Genetics' Partner Celladon Corporation Reports Positive Phase 2 Clinical Trial Data at Heart Failure Association Annual Meeting 04/28/10 Targeted Genetics' Partner, Celladon Corporation, Reports Achievement of Primary Endpoints in Phase II Clinical Trial of MYDICAR(R) for the Treatment of Advanced Heart Failure 04/16/10 Targeted Genetics Reports Board Changes 02/09/10 Targeted Genetics Receives Milestone Payments 01/20/10 Targeted Genetics Corporation Receives Delisting Determination 01/13/10 Targeted Genetics Announces Decision to Delist and Deregister Its Common Stock

Copyright 2009 Targeted Genetics Corporation. Site Terms and Conditions